MANHATTAN BEACH, Calif., April 25, 2016 /PRNewswire-USNewswire/ -- A research study conducted by the Pancreatic Cancer Action Network was the most cited paper of 2014 in the journal Cancer Research. To date, the study has been cited over 300 times.
"Our study was a call to action to the scientific and clinical communities, as well as the population at large, to increase attention, awareness and ultimately progress in the fight against pancreatic cancer," said Lynn Matrisian, PhD, MBA, chief research officer at the Pancreatic Cancer Action Network and senior author on the prized research study. "The disease is still one of the deadliest, with a five-year survival rate of just 8 percent."
The research study, "Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States," predicted pancreatic cancer would move from the fourth to the second leading cause of cancer-related death in the United States around 2020.
It further predicted that by the year 2030, the top five deadliest cancers in the United States will be lung, pancreatic, liver, colorectal and breast – a dramatic shift from the 2014 top deadliest cancers: lung, colorectal, breast, pancreatic and prostate. The study also pointed out a rapid rise in the number of cases of thyroid cancer.
These predictions are quickly becoming reality.
In early Jan. 2016, pancreatic cancer moved from the fourth to the third leading cause of cancer-related death in the U.S. And, the top five cancer killers have since shifted to lung, colorectal, pancreatic, breast and liver.
The award was bestowed based on the total number of citations from date of publication, May 19, 2014, through Jan. 2016. The journal Cancer Research is a publication of the American Association for Cancer Research (AACR).
"We are proud of how often the study has been cited," Matrisian said. "It's a reflection of an interest in looking to the future to inform today's research efforts, as well as the growth and commitment happening within the pancreatic cancer community."
Learn more about the Pancreatic Cancer Action Network by visiting http://www.pancan.org/.
About the Pancreatic Cancer Action Network
The Pancreatic Cancer Action Network is the national organization creating hope in a comprehensive way through research, patient support, community outreach and advocacy for a cure. The organization is leading the way to increase survival for people diagnosed with this devastating disease through a bold initiative — The Vision of Progress: Double Pancreatic Cancer Survival by 2020. To continue to accelerate progress, a goal to raise $200 million by 2020 is also in place. Together, we can Wage Hope and rewrite the future of pancreatic cancer.
Senior Manager, Public Relations
Pancreatic Cancer Action Network
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/pancreatic-cancer-action-network-research-study-most-cited-paper-from-2014-in-the-prestigious-journal-cancer-research-300256329.html
SOURCE Pancreatic Cancer Action Network